Clinical Trial Update: A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of JNJ-63733657 in healthy subjects and individuals with Alzheimer disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• JNJ-63733657

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED